Abstract
Abstract. The prevalence of autism spectrum disorders (ASD) has risen sharply in the last 30 years, posing a major public health concern and a big emotional and financial challenge for families. While the underlying causes remain to be fully elucidated, evidence shows moderate genetic heritability contribution, but heavy environmental influence. Over the last decades, modern lifestyle has deeply changed our eating, rest, and exercise habits, while exposure to air, water, and food chemical pollution has increased due to indiscriminate use of pesticides, food additives, adjuvants, and antibiotics. The result is a drastic change in the quality of our energy source input, and an overload for antioxidant and detoxification pathways that compromises normal metabolism and homeostasis. Current research shows high prevalence of food selectivity and/or food allergy among children with autism, resulting in essential micronutrient deficits that may trigger or aggravate physical and cognitive symptoms. Nutrigenomics is an emerging discipline that focuses on genotype-micronutrient interaction, and a useful approach to tailor low risk, personalized interventions through diet and micronutrient supplementation. Here, we review available literature addressing the role of micronutrients in the symptomatology of ASD, the metabolic pathways involved, and their therapeutic relevance. Personalized and supervised supplementation according to individual needs is suggested as a complement of traditional therapies to improve outcome both for children with autism and their families.
References
1 . Diagnostic and statistical manual of mental disorders. J. Dev. Behav. Pediatr. 2013;34:261.
2 . Characterizing the interplay between Autism Spectrum Disorder and comorbid medical conditions: An integrative review. Front. Psychiatry. 2019;9:751.
3 The co-morbidity burden of children and young adults with Autism Spectrum Disorders. In Smalheiser NRed., PLoS One. 2012;7:e33224.
4 Prevalence of Autism Spectrum Disorder among children aged 8 years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. MMWR. Surveill. Summ. 2018;67:1–23.
5 . 2019. Autism Spectrum Disorder. [cited 30 September 2019]. Available from https://www.cdc.gov/ncbddd/autism/index.html.
6 Trends in the prevalence of developmental disabilities in US children, 1997–2008. Pediatrics. 2011;127:1034–1042.
7 . Change in autism diagnoses prior to and following the introduction of DSM-5. J. Autism Dev. Disord. 2017;47:163–171.
8 . Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Am. J. Psychiatry. 1995;152:1228.
9 . Explaining the increase in the prevalence of Autism Spectrum Disorders: The proportion attributable to changes in reporting practices. JAMA Pediatr. 2015;169:56–62.
10 . Brief report: Forecasting the economic burden of autism in 2015 and 2025 in the United States. J. Autism Dev. Disord. 2015;45:4135–4139.
11 Identification of common genetic risk variants for Autism Spectrum Disorder. Nat. Genet. 2019;51:431–444.
12 . Professional practice and guidelines committee. Clinical genetics evaluation in identifying the etiology of Autism Spectrum Disorders. Genet. Med. 2008;10:301–305.
13 . Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry. 2011;68:1095.
14 Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol. Psychiatry. 2014;19:495–503.
15 Environmental factors in the development of Autism Spectrum Disorders. Environ. Int. 2016;88:288–298.
16 Prenatal and infant exposure to ambient pesticides and Autism Spectrum Disorder in children: Population based case-control study. BMJ. 2019;364:l962.
17 . Neurodevelopmental disorders and environmental toxicants: Epigenetics as an underlying mechanism. Int. J. Genomics. 2017;2017:1–23.
18 . Mean serum-level of common organic pollutants is predictive of behavioral severity in children with Autism Spectrum Disorders. Sci. Rep. 2016;6:26185.
19 . A longitudinal cohort study of the relationship between Thimerosal-containing hepatitis B vaccination and specific delays in development in the United States: Assessment of attributable risk and lifetime care costs. J. Epidemiol. Glob. Health. 2016;6:105–118.
20 Exposure to antibiotics in the first 24 months of life and neurocognitive outcomes at 11 years of age. Psychopharmacology (Berl). 2019;236:1573–1582.
21 . Are endocrine disrupting compounds environmental risk factors for autism spectrum disorder? Horm. Behav. 2018;101:13–21.
22 . Assessing progress and outcome of early intensive behavioral intervention for toddlers with autism. Res. Dev. Disabil. 2014;35:3632–3644.
23 . Nonmedical interventions for children with asd: recommended guidelines and further research needs. Pediatrics. 2012;130:169–178.
24 Comprehensive nutritional and dietary intervention for autism spectrum disorder – A randomized, controlled 12-month trial. Nutrients. 2018;10:369.
25 . Maternal and foetal health implications of vitamin D status during pregnancy. Ann. Nutr. Metab. 2018;72:179–192.
26 Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder. Nutr. Neurosci. 2017;20:284–290.
27 Maternal multivitamin intake, plasma folate and vitamin B 12 levels and Autism Spectrum Disorder risk in offspring. Paediatr. Perinat. Epidemiol. 2018;32:100–111.
28 Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol. Psychiatry. 2018;23:247–256.
29 . Effects of micronutrients on placental function: evidence from clinical studies to animal models. Reproduction. 2018;156:R69–R82.
30 Common genetic variants, acting additively, are a major source of risk for autism. Mol. Autism. 2012;3:9.
31 . Epigenetic findings in Autism: New perspectives for therapy. Int. J. Environ. Res. Public Health. 2013;10:4261–4273.
32 . Prenatal exposure to common environmental factors affects brain lipids and increases risk of developing Autism Spectrum Disorders. In Molholm Sed., Eur. J. Neurosci. 2015;42:2742–2760.
33 Prenatal vitamins, One-carbon metabolism gene variants, and risk for autism. Epidemiology. 2011;22:476–485.
34 Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain. Pharmacol. Reports. 2015;67:560–568.
35 . Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 2009;390:191–214.
36 . Oxidative stress and excitotoxicity: antioxidants from nutraceuticals. Nutraceuticals. 2016;401–413. https://doi.org/10.1016/B978-0-12-802147-7.00029-2
37 Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2006;141B:947–956.
38 Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders. Int. J. Dev. Neurosci. 2015;46:27–32.
39 . Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: Alterations in the activities and protein expression of glutathione-related enzymes. Free Radic. Biol. Med. 2013;65:488–496.
40 . Genetic variant of glutathione peroxidase 1 in autism. Brain Dev. 2010;32:105–109.
41 Interaction between GSTT1 and GSTP1 allele variants as a risk modulating-factor for autism spectrum disorders. Res. Autism Spectr. Disord. 2015;12:1–9.
42 . Measurement of serum superoxide dismutase and its relevance to disease intensity autistic children. Maedica (Buchar). 2015;10:315–318.
43 . A certain role of SOD/CAT imbalance in pathogenesis of Autism Spectrum Disorders. Free Radic. Biol. Med. 2018;123:85–95.
44 Bioenergetic variation is related to autism symptomatology. Metab. Brain Dis. 2017;32:2021–2031.
45 . Clinical and molecular characteristics of mitochondrial dysfunction in Autism Spectrum Disorder. Mol. Diagn. Ther. 2018;22:571–593.
46 . Redox metabolism abnormalities in autistic children associated with mitochondrial disease. Transl. Psychiatry. 2013;3:e273.
47 . Epigenetics and Autism. Autism Res. Treat. 2013;2013:1–9.
48 Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J. Autism Dev. Disord. 2012;42:367–377.
49 . Gene-Environment Interactions and Epigenetic pathways in autism: the importance of one-carbon metabolism. ILAR J. 2012;53:322–340.
50 . Autism: a redox/methylation disorder. Glob. Adv. Heal. Med. 2013;2:68–73.
51 . Dysregulation of cortical neuron DNA methylation profile in Autism Spectrum Disorder. Cereb. Cortex. 2017;27:5739–5754.
52 . A new role for glutathione: Protection of vitamin B 12 from depletion by xenobiotics. Chem. Res. Toxicol. 2004;17:1562–1567.
53 Decreased brain levels of vitamin B12 in aging, autism and schizophrenia. In Bauer JAed., PLoS One. 2016;11:e0146797.
54 . Role of a redox-based methylation switch in mRNA life cycle (pre- and post-transcriptional maturation) and protein turnover: implications in neurological disorders. Front. Neurosci. 2012;6:92.
55 The emerging field of epitranscriptomics in neurodevelopmental and neuronal disorders. Front. Bioeng. Biotechnol. 2018;6:46.
56 Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism. In Phillips Wed., PLoS One. 2013;8:e56927.
57 . Analysis of methionine synthase (rs1805087) gene polymorphism in autism patients in Northern Iran. Acta Neurobiol. Exp. (Wars). 2016;76:318–323.
58 . A key role for an impaired detoxification mechanism in the etiology and severity of autism spectrum disorders. Behav. Brain Funct. 2014;10:14.
59 Project TENDR: Targeting environmental neuro-developmental risks the TENDR consensus statement. Environ. Health Perspect. 2016;124:A118–22.
60 . Editorial: Developmental neurotoxicity. Toxicol. Appl. Pharmacol. 2018;354:1–2.
61 Epigenetic assessment of environmental chemicals detected in maternal peripheral and cord blood samples. J. Reprod. Dev. 2011;57:507–17.
62 . A comparison of food refusal related to characteristics of food in children with autism spectrum disorder and typically developing children. J. Acad. Nutr. Diet. 2014;114:1981–1987.
63 . Feeding problems and nutrient intake in children with and without autism: A comparative study. Indian J. Pediatr. 2017;84:283–288.
64 Food selectivity in a diverse sample of young children with and without intellectual disabilities. Appetite. 2019;133:433–440.
65 . Warburg effect hypothesis in Autism Spectrum Disorders. Mol. Brain. 2018;11:1.
66 Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. In Jacobson Sed., PLoS One. 2011;6:e24585.
67 Vitamin A and vitamin D deficiencies exacerbate symptoms in children with Autism Spectrum Disorders. Nutr. Neurosci. 2018;16:1–11.
68 . Brief report: Scurvy as a manifestation of food selectivity in children with autism. J. Autism Dev. Disord. 2016;46:1464–1470.
69 . Treatments for biomedical abnormalities associated with autism spectrum disorder. Front. Pediatr. 2014;2:66.
70 . The effects of different combinations of perceptual-motor exercises, music, and vitamin D supplementation on the nerve growth factor in children with high-functioning autism. Complement. Ther. Clin. Pract. 2018;31:139–145.
71 . Randomized, placebo-controlled trial of methyl B12 for children with autism. J. Child Adolesc. Psychopharmacol. 2016;26:774–783.
72 Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr. Neurosci. 2016;19:346–351.
73 . Autism: Will vitamin D supplementation during pregnancy and early childhood reduce the recurrence rate of autism in newborn siblings? Med. Hypotheses. 2016;88:74–78.
74 . Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. Magnes. Res. 2006;19:46–52.
75 . The role of marine omega-3 in human neurodevelopment, including Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder – a review. Crit. Rev. Food Sci. Nutr. 2019;1–16.
76 Effect of pioglitazone treatment on behavioral symptoms in autistic children. J. Neuroinflammation. 2007;4:7.
77 . Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease. J. Physiol. Pharmacol. 2016;67:3–19.
78 . Biomedical aspects of pyridoxal 5-phosphate availability. Front. Biosci. 2012;E4:428.
79 Neuropathological mechanisms of seizures in Autism Spectrum Disorder. Front. Neurosci. 2016;10:192.
80 . Reduced GABA synthesis in pyridoxine-dependent seizures. Lancet. 1994;343:1133–1134.
81 . Neurobiological bases of autism-epilepsy comorbidity: a focus on excitation/inhibition imbalance. Eur. J. Neurosci. 2018;47:534–548.
82 . Autistic traits and components of the folate metabolic system: an explorative analysis in the eastern Indian ASD subjects. Nutr. Neurosci. 2019;1–8. https://doi.org/10.1080/1028415X.2019.1570442
83 . The levels of vitamin D, vitamin D receptor, homocysteine and complex B vitamin in children with Autism Spectrum Disorders. Clin. Psychopharmacol. Neurosci. 2018;16:383–390.
84 . Abnormally high plasma levels of vitamin B 6 in children with autism not taking supplements compared to controls not taking supplements. J. Altern. Complement. Med. 2006;12:59–63.
85 Common variants at putative regulatory sites of the tissue nonspecific alkaline phosphatase gene influence circulating pyridoxal 5′-phosphate concentration in healthy adults. J. Nutr. 2015;145:1386–1393.
86 . Magnesium, hyperactivity and autism in children. Magnes. Cent. Nerv. Syst. 2011. [cited 25 April 2019]. Available from http://www.ncbi.nlm.nih.gov/pubmed/29920003
87 . Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst. Rev. 2005;CD003497.
88 . Folate metabolism abnormalities in autism: potential biomarkers. Biomark. Med. 2017;11:687–699.
89 . Linking genetics to epigenetics: The role of folate and folate-related pathways in neurodevelopmental disorders. Clin. Genet. 2019;95:241–252.
90 . Study of the C677T and 1298AC polymorphic genotypes of MTHFR gene in Autism Spectrum Disorder. Electron. Physician. 2017;9:5287–5293.
91 . Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism. Neurosci. Lett. 2007;422:24–29.
92 A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2010;153B:1209–20.
93 Folate receptor autoantibodies are prevalent in children diagnosed with Autism Spectrum Disorder, their normal siblings and parents. Autism Res. 2018;11:707–712.
94 High prevalence of serum folate receptor autoantibodies in children with Autism Spectrum Disorders. Biomarkers. 2018;23:622–624.
95 . Amnionless (AMN) mutations in Imerslund-Gräsbeck syndrome may be associated with disturbed vitamin B12 transport into the CNS. J. Inherit. Metab. Dis. 2008;31:493–496.
96 . How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. Neurotoxicology. 2008;29:190–201.
97 . Vitamin B 12 and Redox homeostasis: Cob(II)alamin reacts with superoxide at rates approaching superoxide dismutase (SOD). J. Am. Chem. Soc. 2009;131:15078–15079.
98 . Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur. J. Hum. Genet. 2002;10:433–438.
99 An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1). Birth Defects Res. Part A Clin. Mol. Teratol. 2009;85:216–226.
100 . Scan-Statistic approach identifies clusters of rare disease variants in LRP2, a gene linked and associated with Autism Spectrum Disorders, in three datasets. Am. J. Hum. Genet. 2012;90:1002–1013.
101 . Prevention of neural tube defects in Lrp2 mutant mouse embryos by folic acid supplementation. Birth defects Res. 2017;109:16–26.
102 . Retinoic acid and retinoic acid receptors as pleiotropic modulators of the immune system. Annu. Rev. Immunol. 2016;34:369–394.
103 . Vitamin A and retinoid signaling: genomic and nongenomic effects. J. Lipid Res. 2013;54:1761–1775.
104 Excessive UBE3A dosage impairs retinoic acid signaling and synaptic plasticity in autism spectrum disorders. Cell Res. 2018;28:48–68.
105 Vitamin A deficiency impairs spatial learning and memory: The mechanism of abnormal CBP-dependent histone acetylation regulated by retinoic acid receptor alpha. Mol. Neurobiol. 2015;51:633–647.
106 Elevated fetal steroidogenic activity in autism. Mol. Psychiatry. 2015. https://doi.org/10.1038/mp.2014.48.
107 . Investigation of sex differences in the expression of RORA and its transcriptional targets in the brain as a potential contributor to the sex bias in autism. Mol. Autism. 2015;6:7.
108 . Differential recruitment of coregulators to the RORA promoter adds another layer of complexity to gene (dys) regulation by sex hormones in autism. Mol. Autism. 2013;4:39.
109 . The orphan nuclear receptor RORα regulates circadian transcription of the mammalian core-clock Bmal1. Nat. Struct. Mol. Biol. 2005;12:441–448.
110 Human retinoic acid receptor-related orphan receptor 1 overexpression protects neurones against oxidative stress-induced apoptosis. J. Neurochem. 2006;96:1778–1789.
111 . Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J. 2010;24:3036–51.
112 . Developmental vitamin D deficiency and autism: Putative pathogenic mechanisms. J. Steroid Biochem. Mol. Biol. 2018;175:108–118.
113 . Vitamin D – Effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5:111–148.
114 Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians. Ital. J. Pediatr. 2018;44:51.
115 . Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch. Biochem. Biophys. 2012;523:95–102.
116 Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2011;96:1911–1930.
117 . Autism and vitamin D. Med. Hypotheses. 2008;70:750–759.
118 . A review of prevalence studies of Autism Spectrum Disorder by latitude and solar irradiance impact. Med. Hypotheses. 2017;109:19–24.
119 Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology. 2009;34:247–257.
120 Vitamin D status and Parkinson’s disease: A systematic review and meta-analysis. Neurol. Sci. 2014;35:1723–30.
121 Epilepsy and vitamin D: A comprehensive review of current knowledge. Rev. Neurosci. 2017;28:185–201.
122 . Vitamin D in Neurological Diseases: A Rationale for a Pathogenic Impact. Int. J. Mol. Sci. 2018;19:2245.
123 . Vitamin D supplementation restores suppressed synaptic plasticity in Alzheimer’s disease. Nutr. Neurosci. 2014;17:172–177.
124 status is independently associated with plasma glutathione and cysteine thiol/disulphide redox status in adults. Clin. Endocrinol. (Oxf). 2014;81:458–66.
125 . 1,25(OH) 2 D 3 inhibits oxidative stress and monocyte adhesion by mediating the upregulation of GCLC and GSH in endothelial cells treated with acetoacetate (ketosis). J. Steroid Biochem. Mol. Biol. 2016;159:94–101.
126 Selected vitamin D metabolic gene variants and risk for Autism Spectrum Disorder in the CHARGE Study. Early Hum. Dev. 2015;91:483–489.
127 . Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am. J. Clin. Nutr. 2009;89:634–640.
128 . CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. Diabetes. Metab. Res. Rev. 2007;23:631–636.
129 . Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder. gene. 2016;588:109–114.
130 . Polymorphisms in Vitamin D receptor genes in association with childhood Autism Spectrum Disorder. Dis. Markers. 2018;2018:1–7.
131 . Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in Egyptian children with autism. J. Altern. Complement. Med. 2010;16:641–645.
132 . Low serum levels of 25-hydroxyvitamin D (25-OHD) in children with autism. Trends Psychiatry Psychother. 2012;34:161–163.
133 Serum 25-hydroxyvitamin D levels in Chinese children with autism spectrum disorders. Neuroreport. 2014;25:23–7.
134 Serum concentration of 25-hydroxyvitamin D in Autism Spectrum Disorder: A systematic review and meta-analysis. Eur. Child Adolesc. Psychiatry. 2016;25:341–350.
135 . Lower maternal serum 25(OH) D in first trimester associated with higher autism risk in Chinese offspring. J. Psychosom. Res. 2016;89:98–101.
136 Gestational vitamin D deficiency and Autism Spectrum Disorder. BJPsych Open. 2017;3:85–90.
137 Fluctuations in clinical symptoms with changes in serum 25(OH) vitamin D levels in autistic children: Three cases report. Nutr. Neurosci. 2018;1–4. https://doi.org/10.1080/1028415X.2018.1458421
138 Recurrence risk for Autism Spectrum Disorders: a Baby Siblings Research Consortium study. Pediatrics. 2011;128:e488–95.
139 . Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development. Pediatrics. 2012;129:485–493.
140 The TERE1 protein interacts with mitochondrial TBL2: Regulation of trans-membrane potential, ROS/RNS and SXR target genes. J. Cell. Biochem. 2013;114:2170–2187.
141 . Vitamin K and bone metabolism: A review of the latest evidence in preclinical studies. Biomed Res. Int. 2018;2018:4629383.
142 . Key Pathways and regulators of vitamin K function and intermediary metabolism. Annu. Rev. Nutr. 2018;38:127–151.
143 . Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa. Open Hear. 2016;3:e000325.
144 . Bone density in peripubertal boys with Autism Spectrum Disorders. J. Autism Dev. Disord. 2013;43:1623–1629.
145 . Bone microarchitecture in adolescent boys with Autism Spectrum Disorder. Bone. 2017;97:139–146.
146 . Bone accrual in males with Autism Spectrum Disorder. J. Pediatr. 2017;181(195–201):e6.
147 Nutrition and bone density in boys with Autism Spectrum Disorder. J. Acad. Nutr. Diet. 2018;118:865–877.
148 . Vitamins D and K as pleiotropic nutrients: clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy. Altern. Med. Rev. 2010;15:199–222.
149 . Joint association of low vitamin D and vitamin K status with blood pressure and hypertension. hypertension. 2017;69:1165–1172.
150 . Vitamin K2 improves anxiety and depression but not cognition in rats with metabolic syndrome: A role of blood glucose? Folia Med. (Plovdiv). 2016;58:264–272.
151 Vitamin K has the potential to protect neurons from methylmercury-induced cell death in vitro. J. Neurosci. Res. 2011;89:1052–1058.
152 . Vitamin K2 protects PC12 cells against Aβ (1–42) and H2O2-induced apoptosis via p38 MAP kinase pathway. Nutr. Neurosci. 2018;30:1–10.
153 Vitamin K: Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect. Redox biology. 2018;16:352–358.
154 Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases. Sci. Rep. 2016;6:26759.
155 . Vitamin K deficiency induced by warfarin is associated with cognitive and behavioral perturbations, and alterations in brain sphingolipids in rats. Front. Aging Neurosci. 2018;10:213.
156 . Vitamin K and the nervous system: An overview of its actions. Adv. Nutr. 2012;3:204–212.
157 . Does menaquinone participate in brain astrocyte electron transport? Med. Hypotheses. 2013;81:587–591.
158 Vitamin K2 is a mitochondrial electron carrier that rescues Pink1 deficiency. Science. 2012;336:1306–1310.
159 Membrane organization and regulation of cellular cholesterol homeostasis. J. Membr. Biol. 2010;234:183–194.
160 Role of plasma membrane lipid composition on cellular homeostasis: learning from cell line models expressing fatty acid desaturases. Acta Biochim. Biophys. Sin. (Shanghai). 2014;46:273–282.
161 The pattern of fatty acids displaced by EPA and DHA following 12 months supplementation varies between blood cell and plasma fractions. Nutrients. 2015;7:6281–93.
162 . Importance of the Omega-6/Omega-3 balance in health and disease: evolutionary aspects of diet. World Rev. Nutr. Diet. 2011;102:10–21.
163 . Core symptoms of autism improved after vitamin d supplementation. Pediatrics. 2015;135:e196–e198.
164 . Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol. Aspects Med. 2017;58:114–129.
165 . Pro-resolving lipid mediators: Agents of anti-ageing? Semin. Immunol. 2018;40:36–48.
166 . Neuroinflammation in autism: Plausible role of maternal inflammation, dietary omega 3, and microbiota. Neural Plast. 2016;2016:1–15.
167 . β-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels. Prostaglandins. Leukot. Essent. Fatty Acids. 2015;92:33–40.
168 . Maternal n-3 polyunsaturated fatty acid deprivation during pregnancy and lactation affects neurogenesis and apoptosis in adult offspring: associated with DNA methylation of brain-derived neurotrophic factor transcripts. Nutr. Res. 2016;36:1013–1021.
169 . Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 2015;29:2207–2222.
170 . Dietary omega-3 fatty acid supplementation for optimizing neuronal structure and function. Mol. Nutr. Food Res. 2010;54:447–56.
171 . Endocannabinoid signaling and memory dynamics: A synaptic perspective. Neurobiol. Learn. Mem. 2017;138:62–77.
172 . The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages. J. Neuroinflammation. 2014;11:78.
173 Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. J. Autism Dev. Disord. 2013;43:2686–2695.
174 . Emerging class of omega-3 fatty acid endocannabinoids & their derivatives. Prostaglandins Other Lipid Mediat. 2019;143:106337.
175 . Role of liver X receptor, insulin and peroxisome proliferator activated receptor α on in vivo desaturase modulation of unsaturated fatty acid biosynthesis. Lipids. 2007;42:197–210.
176 . Distinct but complementary contributions of PPAR isotypes to energy homeostasis. J. Clin. Invest. 2017;127:1202–1214.
177 . Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors. Inflamm. Res. 2019;68:443–458.
178 Omega 3 polyunsaturated fatty acid improves spatial learning and hippocampal peroxisome proliferator activated receptors (PPARα and PPARγ) gene expression in rats. BMC Neurosci. 2012;13:109.
179 . Nuclear peroxisome proliferator-activated receptors (PPARs) as therapeutic targets of resveratrol for autism spectrum disorder. Int. J. Mol. Sci. 2019;20:1878.
180 . Benefits of Fenofibrate in prenatal valproic acid-induced Autism Spectrum Disorder related phenotype in rats. Brain Res. Bull. 2019;147:36–46.
181 Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice. Mol. Metab. 2015;4:528–536.
182 Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial. J. Psychiatr. Res. 2018;103:104–111.
183 . The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model. Neurochem. Int. 2018;120:251–261.
184 . Autistic children exhibit decreased levels of essential fatty acids in red blood cells. Int. J. Mol. Sci. 2015;16:10061–76.
185 FADS1-FADS2 and ELOVL2 gene polymorphisms in susceptibility to autism spectrum disorders in Chinese children. BMC Psychiatry. 2018;18:283.
186 Genetic variants of the FADS gene cluster and ELOVL gene family, colostrums LC-PUFA levels, breastfeeding, and child cognition. In Moran Med., PLoS One. 2011;6:e17181.
187 . The possible role of the microbiota-gut-brain-axis in Autism Spectrum Disorder. Int. J. Mol. Sci. 2019;20:2115.
188 . Role of probiotics in managing gastrointestinal dysfunction in children with Autism Spectrum Disorder: An update for practitioners. Adv. Nutr. 2018;9:637–650.
189 . Retinoic acid signaling in spinal cord development. Int. J. Biochem. Cell Biol. 2013;45:1302–1313.
190 . The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci. Signal. 2009;2:re4.
191 . Vitamin D effects on pregnancy and the placenta. placenta. 2010;31:1027–1034.
192 . Vitamin K: Novel molecular mechanisms of action and its roles in osteoporosis. Geriatr. Gerontol. Int. 2014;14:1–7.
